Integrated Investment Consultants, LLC Gsk PLC Transaction History

Integrated Investment Consultants, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 19, 2022	SELL	$42.05 - $47.77 $524,994 - $596,408	-12,485 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$40.23 - $47.74 $40,310 - $47,835	1,002 Added 8.73%	12,485 $544,000
Q4 2021 Jan 10, 2022	BUY	$38.88 - $45.31 $2,216 - $2,582	57 Added 0.5%	11,483 $506,000
Q3 2021 Oct 28, 2021	SELL	$38.79 - $43.16 $113,228 - $125,984	-2,919 Reduced 20.35%	11,426 $437,000
Q2 2021 Jul 21, 2021	BUY	$36.52 - $41.46 $407,745 - $462,900	11,165 Added 351.1%	14,345 $571,000
Q1 2018 Apr 12, 2018	BUY	$36.18 - $40.15 $14,833 - $16,461	410 Added 14.8%	3,180 $124,000
Q3 2017 Oct 26, 2017	BUY	$39.44 - $41.55 $109,248 - $115,093	2,770	2,770 $112,000

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $69.2B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Integrated Investment Consultants, LLC, based on Form 13F filings with the SEC.

Stay updated on Integrated Investment Consultants, LLC with notifications on news.